Crystal structure of the human glucose transporter GLUT1
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
The glucose transporter GLUT1 catalyses facilitative diffusion of glucose into erythrocytes and is responsible for glucose supply to the brain and other organs. Dysfunctional mutations may lead to GLUT1 deficiency syndrome, whereas overexpression of GLUT1 is a prognostic indicator for cancer. Despite decades of investigation, the structure of GLUT1 remains unknown. Here we report the crystal structure of human GLUT1 at 3.2 Å resolution. The full-length protein, which has a canonical major facilitator superfamily fold, is captured in an inward-open conformation. This structure allows accurate mapping and potential mechanistic interpretation of disease-associated mutations in GLUT1. Structure-based analysis of these mutations provides an insight into the alternating access mechanism of GLUT1 and other members of the sugar porter subfamily. Structural comparison of the uniporter GLUT1 with its bacterial homologue XylE, a proton-coupled xylose symporter, allows examination of the transport mechanisms of both passive facilitators and active transporters.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Briefly, the U-shaped intracellular helical bundle of GLUT1 is formed by three helixes and functions as a latch to secure GLUT1 in the outward open conformation making the sugar binding site accessible extracellularly (141).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
In the citing paper
“GLUT1 has a single binding site that can be accessed by glucose (and other hexoses) from either side of the luminal and/or abluminal endothelial membrane extracellularly or intracellularly (141).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
In the citing paper
“GLUT1 is expressed in endothelial cells, but not in neurons (141, 649).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
In the citing paper
“After binding to the extracellular binding site, glucose enters GLUT1, which leads to a conformational change causing extracellular transmembrane domains 1, 4, and 7 to function as a latch to secure the inward open conformation of GLUT1 enabling release of glucose intracellularly (141).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
In the citing paper
“Since glucose concentration is lower in the brain interstitial fluid (ISF) compared with plasma, GLUT1 favors blood-to-brain transport of circulating glucose (141, 390, 649).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
(1978) · Biochemical Education · doi:10.1016/0307-4412(78)90049-3 · Cited by 5,046
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
Pao, S. S., Paulsen, I. T., & Saier, M. H. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.1-34.1998 · Cited by 2,297
Sequence and Structure of a Human Glucose Transporter
Mueckler, M., Caruso, C., Baldwin, S. A., Panico, M., Blench, I., Morris, H. R., Allard, W. J., Lienhard, G. E., & Lodish, H. F. (1985) · Science · doi:10.1126/science.3839598 · Cited by 1,547
Simple Allosteric Model for Membrane Pumps
JARDETZKY, O. (1966) · Nature · doi:10.1038/211969a0 · Cited by 1,291
Glucose transporters in the 21st Century
Thorens, B., & Mueckler, M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00712.2009 · Cited by 1,013
Reconstitution and Purification of the D-Glucose Transport Protein from Human Erythrocytes
Kasahara, M., & Hinkle, P. C. (1977) · Proceedings in Life Sciences · doi:10.1007/978-3-642-66564-6_25 · Cited by 651
The ABCs of membrane transporters in health and disease (SLC series): Introduction
Hediger, M. A., Clémençon, B., Burrier, R. E., & Bruford, E. A. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.12.009 · Cited by 646
Pardridge, W. M., Boado, R. J., & Farrell, C. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38267-x · Cited by 606
Reconstitution and purification of the D-glucose transporter from human erythrocytes.
Kasahara, M., & Hinkle, P. C. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)66976-0 · Cited by 572
CHAINSAW: a program for mutating pdb files used as templates in molecular replacement
Stein, N. (2008) · Journal of Applied Crystallography · doi:10.1107/s0021889808006985 · Cited by 543
Glucose transporter proteins in brain
Maher, F., Vannucci, S. J., & Simpson, I. A. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.13.7926364 · Cited by 511
Crystal structure of a bacterial homologue of glucose transporters GLUT1–4
Sun, L., Zeng, X., Yan, C., Sun, X., Gong, X., Rao, Y., & Yan, N. (2012) · Nature · doi:10.1038/nature11524 · Cited by 471
Self-citationLeen, W. G., Klepper, J., Verbeek, M. M., Leferink, M., Hofste, T., van Engelen, B. G., Wevers, R. A., Arthur, T., Bahi-Buisson, N., Ballhausen, D., et al. (2010) · Brain · doi:10.1093/brain/awp336 · Cited by 420
Structural advances for the major facilitator superfamily (MFS) transporters
Yan, N. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.01.003 · Cited by 418
Self-citationMammalian and bacterial sugar transport proteins are homologous
Maiden, M. C. J., Davis, E. O., Baldwin, S. A., Moore, D. C. M., & Henderson, P. J. F. (1987) · Nature · doi:10.1038/325641a0 · Cited by 398
Inborn Metabolic Diseases: Diagnosis and Treatment
(2012) · doi:10.1007/978-3-642-15720-2 · Cited by 377
GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis
Amann, T., Maegdefrau, U., Hartmann, A., Agaimy, A., Marienhagen, J., Weiss, T. S., Stoeltzing, O., Warnecke, C., Schölmerich, J., Oefner, P. J., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080596 · Cited by 368
Weber, Y. G., Storch, A., Wuttke, T. V., Brockmann, K., Kempfle, J., Maljevic, S., Margari, L., Kamm, C., Schneider, S. A., Huber, S. M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34438 · Cited by 363
Glut‐1 deficiency syndrome: Clinical, genetic, and therapeutic aspects
Wang, D., Pascual, J. M., Yang, H., Engelstad, K., Jhung, S., Sun, R. P., & De Vivo, D. C. (2005) · Annals of Neurology · doi:10.1002/ana.20331 · Cited by 329
Early‐onset absence epilepsy caused by mutations in the glucose transporter GLUT1
Suls, A., Mullen, S. A., Weber, Y. G., Verhaert, K., Ceulemans, B., Guerrini, R., Wuttke, T. V., Salvo‐Vargas, A., Deprez, L., Claes, L. R. F., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21724 · Cited by 299
Common Folds and Transport Mechanisms of Secondary Active Transporters
Shi, Y. (2013) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-083012-130429 · Cited by 276
Structure of a fucose transporter in an outward-open conformation
Dang, S., Sun, L., Huang, Y., Lu, F., Liu, Y., Gong, H., Wang, J., & Yan, N. (2010) · Nature · doi:10.1038/nature09406 · Cited by 274
Self-citationDick, A. P., Harik, S. I., Klip, A., & Walker, D. M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.7233 · Cited by 247
The expanding phenotype of GLUT1-deficiency syndrome
Brockmann, K. (2009) · Brain and Development · doi:10.1016/j.braindev.2009.02.008 · Cited by 234
Phenotypic Spectrum of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Pearson, T. S., Akman, C., Hinton, V. J., Engelstad, K., & De Vivo, D. C. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0342-7 · Cited by 227
Inborn Metabolic Diseases: Diagnosis and Treatment
Zeman, J. (2012) · Acta Paediatrica · doi:10.1111/j.1651-2227.2012.02755.x · Cited by 212
GLUT1 as a therapeutic target in hepatocellular carcinoma
Amann, T., & Hellerbrand, C. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903307509 · Cited by 204
The Alternating-Access Mechanism of MFS Transporters Arises from Inverted-Topology Repeats
Radestock, S., & Forrest, L. R. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.02.008 · Cited by 194
Imaging the metabolic footprint of Glut1 deficiency on the brain
Pascual, J. M., Heertum, R. L. V., Wang, D., Engelstad, K., & Vivo, D. C. D. (2002) · Annals of Neurology · doi:10.1002/ana.10311 · Cited by 161
Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency
Mullen, S. A., Suls, A., De Jonghe, P., Berkovic, S. F., & Scheffer, I. E. (2010) · Neurology · doi:10.1212/wnl.0b013e3181eb58b4 · Cited by 160
Mutational analysis of GLUT1 (SLC2A1) in Glut-1 Deficiency Syndrome
Wang, D., Kranz‐Eble, P., & Vivo, D. C. D. (2000) · Human Mutation · doi:10.1002/1098-1004(200009)16:3<224::aid-humu5>3.0.co;2-p · Cited by 155
Structural basis for substrate transport in the GLUT-homology family of monosaccharide transporters
Quistgaard, E. M., Löw, C., Moberg, P., Tresaugues, L., & Nordlund, P. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2569 · Cited by 143
Crystal structure of a glucose/H + symporter and its mechanism of action
Iancu, C. V., Zamoon, J., Woo, S. B., Aleshin, A. E., & Choe, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311485110 · Cited by 132
Functional architecture of MFS d -glucose transporters
Madej, M. G., Sun, L., Yan, N., & Kaback, H. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400336111 · Cited by 131
Self-citationGLUT1 gene mutations cause sporadic paroxysmal exercise‐induced dyskinesias
Schneider, S. A., Paisán‐Ruiz, C., García‐Gorostiaga, I., Quinn, N. P., Weber, Y. G., Lerche, H., Hardy, J., & Bhatia, K. P. (2009) · Movement Disorders · doi:10.1002/mds.22507 · Cited by 124
Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer
Kaira, K., Serizawa, M., Koh, Y., Takahashi, T., Yamaguchi, A., Hanaoka, H., Oriuchi, N., Endo, M., Ohde, Y., Nakajima, T., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.11.025 · Cited by 123
Autosomal dominant transmission of GLUT1 deficiency
Klepper, J., Willemsen, M., Verrips, A., Guertsen, E., Herrmann, R., Kutzick, C., Flörcken, A., & Voit, T. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.1.63 · Cited by 111
Lactose Permease and the Alternating Access Mechanism
Смирнова, И. Н., Kasho, V. N., & Kaback, H. R. (2011) · Biochemistry · doi:10.1021/bi2014294 · Cited by 111
Defective Glucose Transport Across Brain Tissue Barriers: A Newly Recognized Neurological Syndrome
Klepper, J., Wang, D., Fischbarg, J., Vera, J. C., Jarjour, I. T., O’Driscoll, K. R., & Vivo, D. C. D. (1999) · Neurochemical Research · doi:10.1023/a:1022544131826 · Cited by 109
GLUT1 mutations are a rare cause of familial idiopathic generalized epilepsy
Striano, P., Weber, Y. G., Toliat, M. R., Schubert, J., Leu, C., Chaimana, R., Baulac, S., Guerrero, R., Leguern, É., Lehesjoki, A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318247ff54 · Cited by 96
Schürmann, A., Doege, H., Ohnimus, H., Monser, V., Buchs, A. E., & Joost, H. (1997) · Biochemistry · doi:10.1021/bi971173c · Cited by 91
GLUT1 deficiency syndrome into adulthood: a follow-up study
Leen, W. G., Taher, M., Verbeek, M. M., Kamsteeg, E., van de Warrenburg, B. P. C., & Willemsen, M. A. A. P. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7240-z · Cited by 90
Autosomal Recessive Inheritance of GLUT1 Deficiency Syndrome
Klepper, J., Scheffer, H., Elsaid, M. F., Kamsteeg, E.-J., Leferink, M., & Ben‐Omran, T. (2009) · Neuropediatrics · doi:10.1055/s-0030-1248264 · Cited by 70
GLUT‐1 deficiency without epilepsy—an exceptional case
Overweg‐Plandsoen, W. C. G., Groener, J. E. M., Wang, D., Onkenhout, W., Brouwer, O. F., Bakker, H. D., & Vivo, D. C. D. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1025999914822 · Cited by 66
Excellent response to acetazolamide in a case of paroxysmal dyskinesias due to GLUT1-deficiency
Anheim, M., Maillart, É., Vuillaumier‐Barrot, S., Flamand‐Rouvière, C., Pineau, F., Ewenczyk, C., Riant, F., Apartis, E., & Roze, E. F. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5702-5 · Cited by 60
Urbizu, A., Cuenca-León, E., Raspall‐Chaure, M., Gratacos, M., Conill, J., Redecillas, S. S., Roig-Quilis, M., & Macaya, A. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.05.017 · Cited by 54
Shim, B. Y., Jung, J., Lee, K., Kim, H., Hong, S. H., Kim, S. H., Sun, D. S., & Cho, H. (2012) · International Journal of Colorectal Disease · doi:10.1007/s00384-012-1542-3 · Cited by 51
Biomarkers in renal cell carcinoma
McGuire, B. B., & Fitzpatrick, J. M. (2009) · Current Opinion in Urology · doi:10.1097/mou.0b013e32832f0c68 · Cited by 47
Ramani, P., Headford, A., & May, M. (2013) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-012-1370-4 · Cited by 40
Childhood Chorea With Cerebral Hypotrophy
Pérez‐Dueñas, B., Prior, C., Ma, Q., Fernández‐Álvarez, E., Setoaín, X., Artuch, R., & Pascual, J. M. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.236 · Cited by 35
Afawi, Z., Suls, A., Ekstein, D., Kivity, S., Neufeld, M. Y., Oliver, K. L., Jonghe, P. D., Korczyn, A. D., & Berkovic, S. F. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02726.x · Cited by 29
Nobel Lectures in Chemistry (2016–2020)
Lidin, S. (2022) · WORLD SCIENTIFIC eBooks · doi:10.1142/12971 · Cited by 24
This is about the in and the out
Henderson, P. J. F., & Baldwin, S. A. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2604 · Cited by 23
Analysis of a promoter polymorphism of the GLUT1 gene in patients with hepatocellular carcinoma
Amann, T., Kirovski, G., Bosserhoff, A., & Hellerbrand, C. (2011) · Molecular Membrane Biology · doi:10.3109/09687688.2011.554447 · Cited by 17
Bundles of insights into sugar transporters
Henderson, P. J. F., & Baldwin, S. A. (2012) · Nature · doi:10.1038/490348a · Cited by 10
Sanderson, N. M., Qi, D., Steel, A., & Henderson, P. J. F. (1998) · Biochemical Society Transactions · doi:10.1042/bst026s306 · Cited by 8
Research works printed but not linked: 1
- Mitchell, P. David Keilin’s respiratory chain concept and its chemiosmotic consequences. In Nobel Lectures, Chemistry 1971–1980 (ed. Forsén, S. ) (World Scientific Publishing Co., 1978)
Cited by
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration
Winkler, E. A., Nishida, Y., Sagare, A. P., Rege, S. V., Bell, R. D., Perlmutter, D., Sengillo, J. D., Hillman, S., Kong, P., Nelson, A. R., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3966 · Cited by 689
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
A Call for Systematic Research on Solute Carriers
César-Razquin, A., Snijder, B., Frappier-Brinton, T., Isserlin, R., Gyimesi, G., Bai, X., Reithmeier, R. A., Hepworth, D., Hediger, M. A., Edwards, A. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.022 · Cited by 580
Metadata
- Authors
- Deng, D., Xu, C., Sun, P., Wu, J., Yan, C., Hu, M., & Yan, N.
- Affiliations
- Center for Life Sciences (CN)
- Tsinghua University (CN)
- Corresponding author
- Yan, Nieng
- Venue
- Nature
- Published
- 2014-05-18
- Volume
- 510
- Issue
- 7503
- Pages
- 121-125
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1987612677
- Cited by
- 777
- References
- 62
- Citations by year
- 2026: 50 · 2025: 64 · 2024: 64 · 2023: 52 · 2022: 72 · 2021: 73 · 2020: 70 · 2019: 59 · 2018: 64 · 2017: 67 · 2016: 57 · 2015: 65 · 2014: 19
- FWCI
- 31.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- GLUT1, glucose transporters, crystal structure, major facilitator superfamily, inward-open conformation, GLUT1 deficiency syndrome, disease-associated mutations, alternating access mechanism, XylE, proton-coupled transport, anticancer drug targets
- MeSH terms
- Carbohydrate Metabolism, Inborn Errors, Humans, Ligands, Models, Biological, Models, Molecular, Monosaccharide Transport Proteins, Mutation, Structure-Activity Relationship, Protein Structure, Tertiary, Crystallography, X-Ray, Symporters, Escherichia coli Proteins, Glucose Transporter Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.